{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T09:47:59Z","timestamp":1784886479722,"version":"3.55.0"},"reference-count":109,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T00:00:00Z","timestamp":1571356800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.omtn.2019.09.031","type":"journal-article","created":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T20:51:57Z","timestamp":1571777517000},"page":"927-937","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Exploring the Potential of MicroRNA Let-7c as a Therapeutic for Prostate Cancer"],"prefix":"10.1016","volume":"18","author":[{"given":"Eoghan J.","family":"Mulholland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William P.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niamh E.","family":"Buckley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen O.","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2019.09.031_bib1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.cancergen.2015.02.010","article-title":"Microdissecting the role of microRNAs in the pathogenesis of prostate cancer","volume":"208","author":"Ayub","year":"2015","journal-title":"Cancer Genet."},{"key":"10.1016\/j.omtn.2019.09.031_bib2","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1517\/14728222.2016.1162294","article-title":"MiRNA 34a: a therapeutic target for castration-resistant prostate cancer","volume":"20","author":"Chalanqui","year":"2016","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.omtn.2019.09.031_bib3","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.eururo.2014.12.037","article-title":"The role of miRNAs in prostate cancer","volume":"68","author":"Sun","year":"2015","journal-title":"Eur. Urol."},{"key":"10.1016\/j.omtn.2019.09.031_bib5","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1056\/NEJMoa031918","article-title":"Prevalence of prostate cancer among men with a prostate-specific antigen level\u00a0< or\u00a0=4.0\u00a0ng per milliliter","volume":"350","author":"Thompson","year":"2004","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtn.2019.09.031_bib6","first-page":"159","article-title":"Purification of a human prostate specific antigen","volume":"17","author":"Wang","year":"1979","journal-title":"Invest. Urol."},{"key":"10.1016\/j.omtn.2019.09.031_bib7","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1056\/NEJMoa0810084","article-title":"Screening and prostate-cancer mortality in a randomized European study","volume":"360","author":"Schr\u00f6der","year":"2009","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtn.2019.09.031_bib8","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.euf.2017.07.007","article-title":"Impact of Prostatic-specific Antigen Threshold and Screening Interval in Prostate Cancer Screening Outcomes: Comparing the Swedish and Finnish European Randomised Study of Screening for Prostate Cancer Centres","volume":"5","author":"Saarim\u00e4ki","year":"2019","journal-title":"Eur. Urol. Focus"},{"key":"10.1016\/j.omtn.2019.09.031_bib10","doi-asserted-by":"crossref","first-page":"6323","DOI":"10.1016\/j.bmc.2007.04.002","article-title":"Synthesis and evaluation of water-soluble docetaxel prodrugs-docetaxel esters of malic acid","volume":"15","author":"Du","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.omtn.2019.09.031_bib11","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1158\/1535-7163.MCT-13-0208","article-title":"Inhibition of ABCB1 expression overcomes acquired docetaxel resistance in prostate cancer","volume":"12","author":"Zhu","year":"2013","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.omtn.2019.09.031_bib12","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12894-017-0206-6","article-title":"miRNAs associated with prostate cancer risk and progression","volume":"17","author":"Luu","year":"2017","journal-title":"BMC Urol."},{"key":"10.1016\/j.omtn.2019.09.031_bib13","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.nano.2016.08.017","article-title":"Anti-CD24 nano-targeted delivery of docetaxel for the treatment of prostate cancer","volume":"13","author":"Bharali","year":"2017","journal-title":"Nanomedicine (Lond.)"},{"key":"10.1016\/j.omtn.2019.09.031_bib14","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.eururo.2015.12.054","article-title":"The Potential of MicroRNAs as Prostate Cancer Biomarkers","volume":"70","author":"Fabris","year":"2016","journal-title":"Eur. Urol."},{"key":"10.1016\/j.omtn.2019.09.031_bib15","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jconrel.2016.04.034","article-title":"Reducible self-assembling cationic polypeptide-based micelles mediate co-delivery of doxorubicin and microRNA-34a for androgen-independent prostate cancer therapy","volume":"232","author":"Yao","year":"2016","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.omtn.2019.09.031_bib16","first-page":"932","article-title":"MiR-34a-3p alters proliferation and apoptosis of meningioma cells in\u00a0vitro and is directly targeting SMAD4, FRAT1 and BCL2","volume":"9","author":"Werner","year":"2017","journal-title":"Aging (Albany N.Y.)"},{"key":"10.1016\/j.omtn.2019.09.031_bib17","unstructured":"miRBase: the microRNA database. http:\/\/www.mirbase.org\/summary.shtml?org=hsa."},{"key":"10.1016\/j.omtn.2019.09.031_bib18","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.eururo.2011.01.044","article-title":"MicroRNA in prostate, bladder, and kidney cancer: a systematic review","volume":"59","author":"Catto","year":"2011","journal-title":"Eur. Urol."},{"key":"10.1016\/j.omtn.2019.09.031_bib19","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.omtn.2017.06.003","article-title":"MicroRNA as Therapeutic Targets for Chronic Wound Healing","volume":"8","author":"Mulholland","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"Pt B","key":"10.1016\/j.omtn.2019.09.031_bib20","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.cca.2015.09.022","article-title":"MicroRNA in prostate cancer","volume":"451","author":"Khanmi","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.omtn.2019.09.031_bib21","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2019.09.031_bib22","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.eururo.2015.09.019","article-title":"Systematic Identification of MicroRNAs That Impact on Proliferation of Prostate Cancer Cells and Display Changed Expression in Tumor Tissue","volume":"69","author":"Aakula","year":"2016","journal-title":"Eur. Urol."},{"key":"10.1016\/j.omtn.2019.09.031_bib23","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/pros.23358","article-title":"MicroRNA-181a promotes docetaxel resistance in prostate cancer cells","volume":"77","author":"Armstrong","year":"2017","journal-title":"Prostate"},{"key":"10.1016\/j.omtn.2019.09.031_bib24","first-page":"3599","article-title":"microRNA-204 modulates chemosensitivity and apoptosis of prostate cancer cells by targeting zinc-finger E-box-binding homeobox 1 (ZEB1)","volume":"9","author":"Wu","year":"2017","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.omtn.2019.09.031_bib25","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000494004","article-title":"MicroRNA-34a Attenuates Paclitaxel Resistance in Prostate Cancer Cells via Direct Suppression of JAG1\/Notch1 Axis","volume":"50","author":"Liu","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.omtn.2019.09.031_bib26","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3390\/genes5030671","article-title":"Computational Methods for MicroRNA Target Prediction","volume":"5","author":"Ekimler","year":"2014","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.omtn.2019.09.031_bib27","doi-asserted-by":"crossref","first-page":"e0152860","DOI":"10.1371\/journal.pone.0152860","article-title":"Predicting miRNA Targets by Integrating Gene Regulatory Knowledge with Expression Profiles","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtn.2019.09.031_bib28","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1093\/bioinformatics\/btt014","article-title":"miRCancer: a microRNA-cancer association database constructed by text mining on literature","volume":"29","author":"Xie","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.omtn.2019.09.031_bib29","doi-asserted-by":"crossref","first-page":"D98","DOI":"10.1093\/nar\/gkn714","article-title":"miR2Disease: a manually curated database for microRNA deregulation in human disease","volume":"37","author":"Jiang","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2019.09.031_bib30","doi-asserted-by":"crossref","first-page":"R6","DOI":"10.1186\/gb-2010-11-1-r6","article-title":"PhenomiR: a knowledgebase for microRNA expression in diseases and biological processes","volume":"11","author":"Ruepp","year":"2010","journal-title":"Genome Biol."},{"key":"10.1016\/j.omtn.2019.09.031_bib31","doi-asserted-by":"crossref","first-page":"F19","DOI":"10.1677\/ERC-09-0184","article-title":"The role of let-7 in cell differentiation and cancer","volume":"17","author":"Boyerinas","year":"2010","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.omtn.2019.09.031_bib32","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.tcb.2008.07.007","article-title":"The let-7 family of microRNAs","volume":"18","author":"Roush","year":"2008","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.omtn.2019.09.031_bib33","doi-asserted-by":"crossref","first-page":"7713","DOI":"10.1158\/0008-5472.CAN-07-1083","article-title":"The let-7 microRNA represses cell proliferation pathways in human cells","volume":"67","author":"Johnson","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.omtn.2019.09.031_bib34","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fgene.2017.00031","article-title":"The LIN28\/let-7 Pathway in Cancer","volume":"8","author":"Balzeau","year":"2017","journal-title":"Front. Genet."},{"key":"10.1016\/j.omtn.2019.09.031_bib35","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.molmed.2008.07.001","article-title":"let-7 microRNAs in development, stem cells and cancer","volume":"14","author":"B\u00fcssing","year":"2008","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.omtn.2019.09.031_bib36","doi-asserted-by":"crossref","first-page":"42680","DOI":"10.1038\/srep42680","article-title":"miR-203 enhances let-7 biogenesis by targeting LIN28B to suppress tumor growth in lung cancer","volume":"7","author":"Zhou","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2019.09.031_bib37","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s13045-017-0507-y","article-title":"Inhibition of LIN28B impairs leukemia cell growth and metabolism in acute myeloid leukemia","volume":"10","author":"Zhou","year":"2017","journal-title":"J.\u00a0Hematol. Oncol."},{"key":"10.1016\/j.omtn.2019.09.031_bib38","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/leu.2016.296","article-title":"The LIN28B\/let-7 axis is a novel therapeutic pathway in multiple myeloma","volume":"31","author":"Manier","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.omtn.2019.09.031_bib39","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1073\/pnas.0808300106","article-title":"Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation","volume":"106","author":"Chang","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2019.09.031_bib40","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s10555-012-9382-8","article-title":"Cancer stem cells, microRNAs, and therapeutic strategies including natural products","volume":"31","author":"Vira","year":"2012","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.omtn.2019.09.031_bib41","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jsbmb.2016.05.006","article-title":"Stem cells and the role of ETS transcription factors in the differentiation hierarchy of normal and malignant prostate epithelium","volume":"166","author":"Archer","year":"2017","journal-title":"J.\u00a0Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.omtn.2019.09.031_bib42","doi-asserted-by":"crossref","first-page":"R83","DOI":"10.1186\/gb-2008-9-5-r83","article-title":"Gene expression profiling of human prostate cancer stem cells reveals a pro-inflammatory phenotype and the importance of extracellular matrix interactions","volume":"9","author":"Birnie","year":"2008","journal-title":"Genome Biol."},{"key":"10.1016\/j.omtn.2019.09.031_bib43","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.stem.2014.02.002","article-title":"Metastatic stem cells: sources, niches, and vital pathways","volume":"14","author":"Oskarsson","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.omtn.2019.09.031_bib44","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.celrep.2016.04.086","article-title":"The RNA Binding Protein IMP2 Preserves Glioblastoma Stem Cells by Preventing let-7 Target Gene Silencing","volume":"15","author":"Degrauwe","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.omtn.2019.09.031_bib45","doi-asserted-by":"crossref","first-page":"e0184644","DOI":"10.1371\/journal.pone.0184644","article-title":"Concurrent treatment with simvastatin and NF-\u03baB inhibitor in human castration-resistant prostate cancer cells exerts synergistic anti-cancer effects via control of the NF-\u03baB\/LIN28\/let-7 miRNA signaling pathway","volume":"12","author":"Kang","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2019.09.031_bib46","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1158\/0008-5472.CAN-15-2665","article-title":"Activation of the Lin28\/let-7 Axis by Loss of ESE3\/EHF Promotes a Tumorigenic and Stem-like Phenotype in Prostate Cancer","volume":"76","author":"Albino","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.omtn.2019.09.031_bib47","doi-asserted-by":"crossref","first-page":"e32832","DOI":"10.1371\/journal.pone.0032832","article-title":"MicroRNA let-7c Is Downregulated in Prostate Cancer and Suppresses Prostate Cancer Growth","volume":"7","author":"Nadiminty","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2019.09.031_bib48","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1074\/jbc.M111.278705","article-title":"MicroRNA let-7c suppresses androgen receptor expression and activity via regulation of Myc expression in prostate cancer cells","volume":"287","author":"Nadiminty","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtn.2019.09.031_bib49","unstructured":"Exiqon miR Search. https:\/\/www.exiqon.com\/miRSearch."},{"key":"10.1016\/j.omtn.2019.09.031_bib50","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2105-11-135","article-title":"miRSel: automated extraction of associations between microRNAs and genes from the biomedical literature","volume":"11","author":"Naeem","year":"2010","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.omtn.2019.09.031_bib51","doi-asserted-by":"crossref","first-page":"D92","DOI":"10.1093\/nar\/gkt1248","article-title":"starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data","volume":"42","author":"Li","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2019.09.031_bib52","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/ncb2783","article-title":"The Lin28b-let-7-Hmga2 axis determines the higher self-renewal potential of fetal haematopoietic stem cells","volume":"15","author":"Copley","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.omtn.2019.09.031_bib53","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.4161\/cc.6.21.4845","article-title":"Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2","volume":"6","author":"Park","year":"2007","journal-title":"Cell Cycle"},{"key":"10.1016\/j.omtn.2019.09.031_bib54","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s13277-015-3853-9","article-title":"Downregulation of HMGA2 inhibits cellular proliferation and invasion, improves cellular apoptosis in prostate cancer","volume":"37","author":"Cai","year":"2016","journal-title":"Tumour Biol."},{"key":"10.1016\/j.omtn.2019.09.031_bib55","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.1038\/onc.2010.215","article-title":"EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer","volume":"29","author":"Singh","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.omtn.2019.09.031_bib56","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrm1835","article-title":"Complex networks orchestrate epithelial-mesenchymal transitions","volume":"7","author":"Thiery","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.omtn.2019.09.031_bib57","doi-asserted-by":"crossref","first-page":"854","DOI":"10.2353\/ajpath.2009.080523","article-title":"HMGA2 maintains oncogenic RAS-induced epithelial-mesenchymal transition in human pancreatic cancer cells","volume":"174","author":"Watanabe","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omtn.2019.09.031_bib58","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s12038-016-9603-3","article-title":"Silencing of HMGA2 promotes apoptosis and inhibits migration and invasion of prostate cancer cells","volume":"41","author":"Shi","year":"2016","journal-title":"J.\u00a0Biosci."},{"key":"10.1016\/j.omtn.2019.09.031_bib59","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1038\/sj.onc.1202748","article-title":"The Myc oncoprotein: a critical evaluation of transactivation and target gene regulation","volume":"18","author":"Cole","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.omtn.2019.09.031_bib60","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nature03677","article-title":"c-Myc-regulated microRNAs modulate E2F1 expression","volume":"435","author":"O\u2019Donnell","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2019.09.031_bib61","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/modpathol.2008.111","article-title":"Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis","volume":"21","author":"Gurel","year":"2008","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.omtn.2019.09.031_bib62","doi-asserted-by":"crossref","first-page":"4765","DOI":"10.1158\/0008-5472.CAN-12-0820","article-title":"B-Raf activation cooperates with PTEN loss to drive c-Myc expression in advanced prostate cancer","volume":"72","author":"Wang","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.omtn.2019.09.031_bib63","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1038\/onc.2015.309","article-title":"Regulation of c-Myc expression by the histone demethylase JMJD1A is essential for prostate cancer cell growth and survival","volume":"35","author":"Fan","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.omtn.2019.09.031_bib64","doi-asserted-by":"crossref","first-page":"e18064","DOI":"10.1371\/journal.pone.0018064","article-title":"Deregulation of MYCN, LIN28B and LET7 in a Molecular Subtype of Aggressive High-Grade Serous Ovarian Cancers","volume":"6","author":"Helland","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2019.09.031_bib65","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1038\/onc.2014.257","article-title":"VEGF drives cancer-initiating stem cells through VEGFR-2\/Stat3 signaling to upregulate Myc and Sox2","volume":"34","author":"Zhao","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.omtn.2019.09.031_bib66","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1053\/j.gastro.2013.10.009","article-title":"Nuclear death receptor TRAIL-R2 inhibits maturation of let-7 and promotes proliferation of pancreatic and other tumor cells","volume":"146","author":"Haselmann","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.omtn.2019.09.031_bib67","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.3892\/or.2015.4123","article-title":"Suppression of casein kinase 2 sensitizes tumor cells to antitumor TRAIL therapy by regulating the phosphorylation and localization of p65 in prostate cancer","volume":"34","author":"Gang","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.omtn.2019.09.031_bib68","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1002\/cncr.25504","article-title":"Recurrence-free survival in prostate cancer is related to increased stromal TRAIL expression","volume":"117","author":"Anees","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.omtn.2019.09.031_bib69","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.molcel.2017.01.021","article-title":"The TRAIL-Induced Cancer Secretome Promotes a Tumor-Supportive Immune Microenvironment via CCR2","volume":"65","author":"Hartwig","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.omtn.2019.09.031_bib70","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/ijc.31374","article-title":"Caspase-3 regulates the migration, invasion and metastasis of colon cancer cells","volume":"143","author":"Zhou","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.omtn.2019.09.031_bib71","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10495-016-1323-5","article-title":"Caspase-3 and caspase-8 expression in breast cancer: caspase-3 is associated with survival","volume":"22","author":"Pu","year":"2017","journal-title":"Apoptosis"},{"key":"10.1016\/j.omtn.2019.09.031_bib72","doi-asserted-by":"crossref","first-page":"e67373","DOI":"10.1371\/journal.pone.0067373","article-title":"Lin28 Mediates Radiation Resistance of Breast Cancer Cells via Regulation of Caspase, H2A.X and Let-7 Signaling","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2019.09.031_bib73","first-page":"1227","article-title":"Loss of caspase-1 and caspase-3 protein expression in human prostate cancer","volume":"61","author":"Winter","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.omtn.2019.09.031_bib74","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1186\/s12885-015-1839-z","article-title":"Prognostic value of inhibitors of apoptosis proteins (IAPs) and caspases in prostate cancer: caspase-3 forms and XIAP predict biochemical progression after radical prostatectomy","volume":"15","author":"Rodr\u00edguez-Berriguete","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.omtn.2019.09.031_bib75","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3389\/fgene.2015.00340","article-title":"Transfection of microRNA Mimics Should Be Used with Caution","volume":"6","author":"Jin","year":"2015","journal-title":"Front. Genet."},{"key":"10.1016\/j.omtn.2019.09.031_bib76","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ymgme.2008.12.016","article-title":"Lessons learned from the gene therapy trial for ornithine transcarbamylase deficiency","volume":"96","author":"Wilson","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtn.2019.09.031_bib77","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejps.2010.03.019","article-title":"Gene delivery by lipoplexes and polyplexes","volume":"40","author":"Tros de Ilarduya","year":"2010","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.omtn.2019.09.031_bib78","doi-asserted-by":"crossref","first-page":"179","DOI":"10.4103\/2230-973X.167646","article-title":"An overview of viral and nonviral delivery systems for microRNA","volume":"5","author":"Yang","year":"2015","journal-title":"Int. J. Pharm. Investig."},{"key":"10.1016\/j.omtn.2019.09.031_bib79","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/mt.2012.67","article-title":"Lipid-based nanoparticle delivery of Pre-miR-107 inhibits the tumorigenicity of head and neck squamous cell carcinoma","volume":"20","author":"Piao","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2019.09.031_bib80","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1002\/pros.22495","article-title":"A panel of five circulating microRNAs as potential biomarkers for prostate cancer","volume":"72","author":"Chen","year":"2012","journal-title":"Prostate"},{"key":"10.1016\/j.omtn.2019.09.031_bib81","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/ijc.24827","article-title":"Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma","volume":"126","author":"Schaefer","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.omtn.2019.09.031_bib82","unstructured":"Clinical Trials Arena.Onpattro (patisiran) for the treatment of polyneuropathy of\u00a0hereditary transthyretin-mediated amyloidosis in adults. https:\/\/www.clinicaltrialsarena.com\/projects\/onpattro-for-hereditary-transthyretin-mediated-amyloidosis\/."},{"key":"10.1016\/j.omtn.2019.09.031_bib83","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.bbrc.2009.03.077","article-title":"MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells","volume":"383","author":"Li","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.omtn.2019.09.031_bib84","doi-asserted-by":"crossref","first-page":"4460","DOI":"10.1038\/onc.2011.624","article-title":"Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer","volume":"31","author":"Jalava","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.omtn.2019.09.031_bib85","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nm.2284","article-title":"The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44","volume":"17","author":"Liu","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2019.09.031_bib86","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.biopha.2017.10.163","article-title":"miR-27b and miR-34a enhance docetaxel sensitivity of prostate cancer cells through inhibiting epithelial-to-mesenchymal transition by targeting ZEB1","volume":"97","author":"Zhang","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.omtn.2019.09.031_bib87","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1158\/0008-5472.CAN-12-0103","article-title":"MiR-96 downregulates REV1 and RAD51 to promote cellular sensitivity to cisplatin and PARP inhibition","volume":"72","author":"Wang","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.omtn.2019.09.031_bib88","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3892\/ijo.2014.2413","article-title":"Loss of miR-100 enhances migration, invasion, epithelial-mesenchymal transition and stemness properties in prostate cancer cells through targeting Argonaute 2","volume":"45","author":"Wang","year":"2014","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.omtn.2019.09.031_bib89","doi-asserted-by":"crossref","first-page":"e70515","DOI":"10.1371\/journal.pone.0070515","article-title":"miR-105 inhibits prostate tumour growth by suppressing CDK6 levels","volume":"8","author":"Honeywell","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2019.09.031_bib90","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12935-015-0189-x","article-title":"MiR-124 suppresses cell motility and adhesion by targeting talin 1 in prostate cancer cells","volume":"15","author":"Zhang","year":"2015","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.omtn.2019.09.031_bib91","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1038\/sj.onc.1210809","article-title":"Widespread deregulation of microRNA expression in human prostate cancer","volume":"27","author":"Ozen","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.omtn.2019.09.031_bib92","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1002\/mc.22204","article-title":"MiR-130b suppresses prostate cancer metastasis through down-regulation of MMP2","volume":"54","author":"Chen","year":"2015","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.omtn.2019.09.031_bib93","first-page":"1967","article-title":"microRNA-133 inhibits cell proliferation, migration and invasion in prostate cancer cells by targeting the epidermal growth factor receptor","volume":"27","author":"Tao","year":"2012","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.omtn.2019.09.031_bib94","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1002\/pros.22501","article-title":"miR-141 modulates androgen receptor transcriptional activity in human prostate cancer cells through targeting the small heterodimer partner protein","volume":"72","author":"Xiao","year":"2012","journal-title":"Prostate"},{"key":"10.1016\/j.omtn.2019.09.031_bib95","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/jhg.2013.121","article-title":"The tumor-suppressive microRNA-143\/145 cluster inhibits cell migration and invasion by targeting GOLM1 in prostate cancer","volume":"59","author":"Kojima","year":"2014","journal-title":"J.\u00a0Hum. Genet."},{"key":"10.1016\/j.omtn.2019.09.031_bib96","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1002\/pros.22878","article-title":"miR-146a functions as a tumor suppressor in prostate cancer by targeting Rac1","volume":"74","author":"Sun","year":"2014","journal-title":"Prostate"},{"key":"10.1016\/j.omtn.2019.09.031_bib97","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/pros.22600","article-title":"Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer","volume":"73","author":"Wu","year":"2013","journal-title":"Prostate"},{"key":"10.1016\/j.omtn.2019.09.031_bib98","doi-asserted-by":"crossref","first-page":"31.e9","DOI":"10.1016\/j.urolonc.2012.11.013","article-title":"miR-154 inhibits prostate cancer cell proliferation by targeting CCND2","volume":"32","author":"Zhu","year":"2014","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.omtn.2019.09.031_bib99","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/pros.23183","article-title":"MicroRNA alteration and putative target genes in high-grade prostatic intraepithelial neoplasia and prostate cancer: STAT3 and ZEB1 are upregulated during prostate carcinogenesis","volume":"76","author":"Cha","year":"2016","journal-title":"Prostate"},{"key":"10.1016\/j.omtn.2019.09.031_bib100","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.4238\/2013.April.2.17","article-title":"MicroRNA-181b expression in prostate cancer tissues and its influence on the biological behavior of the prostate cancer cell line PC-3","volume":"12","author":"He","year":"2013","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.omtn.2019.09.031_bib101","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.3892\/etm.2014.1846","article-title":"microRNA-181 promotes prostate cancer cell proliferation by regulating DAX-1 expression","volume":"8","author":"Tong","year":"2014","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.omtn.2019.09.031_bib102","doi-asserted-by":"crossref","first-page":"e68982","DOI":"10.1371\/journal.pone.0068982","article-title":"Overexpressed microRNA-182 promotes proliferation and invasion in prostate cancer PC-3 cells by down-regulating N-myc downstream regulated gene 1 (NDRG1)","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtn.2019.09.031_bib103","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1038\/bjc.2013.125","article-title":"microRNA-183 is an oncogene targeting Dkk-3 and SMAD4 in prostate cancer","volume":"108","author":"Ueno","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.omtn.2019.09.031_bib104","doi-asserted-by":"crossref","first-page":"e0125576","DOI":"10.1371\/journal.pone.0125576","article-title":"MiR-187 Targets the Androgen-Regulated Gene ALDH1A3 in Prostate Cancer","volume":"10","author":"Casanova-Salas","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtn.2019.09.031_bib105","doi-asserted-by":"crossref","first-page":"e83991","DOI":"10.1371\/journal.pone.0083991","article-title":"miR-200b inhibits prostate cancer EMT, growth and metastasis","volume":"8","author":"Williams","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtn.2019.09.031_bib106","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nm.2645","article-title":"Tyrosine phosphatase SHP2 promotes breast cancer progression and maintains tumor-initiating cells via activation of key transcription factors and a positive feedback signaling loop","volume":"18","author":"Aceto","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtn.2019.09.031_bib107","doi-asserted-by":"crossref","first-page":"e0172787","DOI":"10.1371\/journal.pone.0172787","article-title":"Disturbance of the let-7\/LIN28 double-negative feedback loop is associated with radio- and chemo-resistance in non-small cell lung cancer","volume":"12","author":"Yin","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2019.09.031_bib108","doi-asserted-by":"crossref","first-page":"196","DOI":"10.18632\/oncotarget.2768","article-title":"Targeting ornithine decarboxylase reverses the LIN28\/Let-7 axis and inhibits glycolytic metabolism in neuroblastoma","volume":"6","author":"Lozier","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.omtn.2019.09.031_bib109","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1158\/0008-5472.CAN-14-2215","article-title":"Lin28B\/Let-7 Regulates Expression of Oct4 and Sox2 and Reprograms Oral Squamous Cell Carcinoma Cells to a Stem-like State","volume":"75","author":"Chien","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.omtn.2019.09.031_bib110","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1093\/nar\/gkw099","article-title":"The oncogenic triangle of HMGA2, LIN28B and IGF2BP1 antagonizes tumor-suppressive actions of the let-7 family","volume":"44","author":"Busch","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2019.09.031_bib111","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.cell.2016.04.033","article-title":"SIRT6 Suppresses Pancreatic Cancer through Control of Lin28b","volume":"165","author":"Kugel","year":"2016","journal-title":"Cell"}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S216225311930321X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S216225311930321X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T16:37:28Z","timestamp":1784651848000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S216225311930321X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":109,"alternative-id":["S216225311930321X"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2019.09.031","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the Potential of MicroRNA Let-7c as a Therapeutic for Prostate Cancer","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2019.09.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s).","name":"copyright","label":"Copyright"}]}}